Silence Therapeutics plc

OTCPK:SLNC.F Stock Report

Market Cap: US$983.5m

Silence Therapeutics Management

Management criteria checks 1/4

Silence Therapeutics' CEO is Craig Tooman, appointed in Feb 2022, has a tenure of 2.17 years. total yearly compensation is £7.30M, comprised of 6.5% salary and 93.5% bonuses, including company stock and options. directly owns 0.024% of the company’s shares, worth $236.05K. The average tenure of the management team and the board of directors is 1.6 years and 4.2 years respectively.

Key information

Craig Tooman

Chief executive officer


Total compensation

CEO salary percentage6.5%
CEO tenure2.2yrs
CEO ownership0.02%
Management average tenure1.6yrs
Board average tenure4.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Craig Tooman's remuneration changed compared to Silence Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023UK£7mUK£473k


Sep 30 2023n/an/a


Jun 30 2023n/an/a


Mar 31 2023n/an/a


Dec 31 2022UK£6mUK£461k


Sep 30 2022n/an/a


Jun 30 2022n/an/a


Mar 31 2022n/an/a


Dec 31 2021UK£2mUK£334k


Compensation vs Market: Craig's total compensation ($USD9.22M) is above average for companies of similar size in the US market ($USD3.27M).

Compensation vs Earnings: Craig's compensation has increased whilst the company is unprofitable.


Craig Tooman (58 yo)





Mr. Craig A. Tooman, MBA, serves as President, Chief Executive Officer and Executive Director of Silence Therapeutics plc since February 21, 2022. He has been a Supervisory Director of Curevac N. V. since...

Leadership Team

Craig Tooman
£ 236.0k
Rhonda Hellums
CFO & Secretary2.2yrsUK£2.50m0.0011%
£ 10.5k
Steven Romano
Head of Research & Developmentless than a yearUK£1.82m0.0093%
£ 91.6k
Marie Lindholm
Chief Scientific Officerless than a yearno datano data
Gem Hopkins
Head of IR & Corporate Communicationsno datano datano data
Barbara Ruskin
Senior VP and Chief Intellectual Property & Innovation Officer1.6yrsno datano data
Eric Floyd
Senior Vice President of Regulatory Affairs & Quality Assurance3.8yrsno datano data
J.P. Gabriel
Chief Technical Operations Officer1.4yrsno datano data
Curtis Rambaran
Chief Medical Officerno datano datano data


Average Tenure


Average Age

Experienced Management: SLNC.F's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.

Board Members

Craig Tooman
£ 236.0k
David Lemus
Independent Non-Executive Director5.8yrsUK£184.00k0.0054%
£ 53.0k
Gordon Duff
Chairman of Scientific Advisory Board4.2yrsno datano data
Michael Davidson
Independent Non-Executive Director3.3yrsUK£178.00k0.0093%
£ 91.6k
Iain Ross
Independent Chairman of the Board5yrsUK£402.00k0.079%
£ 775.0k
John Porter
Member of Scientific Advisory Board4.2yrsno datano data
James Ede-Golightly
Independent Non-Executive Director5yrsUK£182.00k0.011%
£ 105.7k
Alistair Gray
Senior Independent Non-Executive Director8.4yrsUK£193.00k0.0054%
£ 53.0k
Henry Ginsberg
Member of Scientific Advisory Board4.2yrsno datano data
Annemieke Aartsma-Rus
Member of Scientific Advisory Board4.2yrsno datano data
John Whittaker
Member of Scientific Advisory Board3.8yrsno datano data
Jenny Sims
Member of Scientific Advisory Board2.3yrsno datano data


Average Tenure


Average Age

Experienced Board: SLNC.F's board of directors are considered experienced (4.2 years average tenure).

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.